Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Publication year range
1.
Ann Endocrinol (Paris) ; 72(3): 198-202, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21640332

ABSTRACT

Thyroid consequences of cancer therapy are multiple, better known after radiotherapy than after chemotherapy and recently described with targeted therapies. Cervical or total body irradiation may result in thyroid insufficiency or cancer. The consequences of treatment with new antiangiogenic drugs are under evaluation; however their effect on thyroid function is already well established. Thyroid dysfunction usually occurs late, several months or years after treatment and have to be depicted. There is an improvement in the overall survival of patients suffering from cancer and endocrinologists must be aware of the endocrine effects of treatments to propose an adequate survey and an appropriate treatment to improve well-being of patients.


Subject(s)
Antineoplastic Agents/adverse effects , Neoplasms/therapy , Thyroid Diseases/etiology , Angiogenesis Inhibitors/adverse effects , Angiogenesis Inhibitors/therapeutic use , Antineoplastic Agents/therapeutic use , Humans , Mitotane/adverse effects , Mitotane/therapeutic use , Neoplasms/drug therapy , Neoplasms/radiotherapy , Protein-Tyrosine Kinases/antagonists & inhibitors , TOR Serine-Threonine Kinases/antagonists & inhibitors , Thyroid Function Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...